victor
defilippi
camilo
raggo
ashle
mose
klau
h
vaccin
gene
therapi
institut
oregon
health
scienc
univers
nw
ave
beaverton
usa
virolog
research
antivir
drug
discoveri
pois
benefit
postgenom
revolut
three
main
reason
first
virus
need
host
replic
therefor
vulner
inhibit
cellular
pathway
knowledg
complet
genom
sequenc
viru
host
permit
studi
interplay
global
scale
combin
transcriptom
proteom
largescal
gene
knockdown
experi
enabl
identif
novel
antivir
target
second
massiv
parallel
assay
system
dna
microarray
defin
postgenom
era
facilit
viral
diagnost
third
combin
genet
genom
enabl
analysi
viral
mutant
strain
unpreced
scale
dramat
effect
viral
infect
host
cell
transcript
pattern
welldocu
briefli
highlight
addit
discuss
recent
trend
appli
function
genom
method
discoveri
new
target
therapi
viral
diseas
virolog
genom
scienc
longer
field
first
complet
genom
sequenc
viral
origin
public
full
viral
genom
sequenc
avail
genbank
http
wwwncbinlmnihgovgenbankindex
html
howev
modern
sequenc
endeavor
made
possibl
complet
sequenc
human
genom
well
model
organ
virogenom
research
aim
describ
interact
product
two
genom
use
postgenom
method
dna
microarray
given
virus
requir
host
organ
propag
approach
promis
deepen
understand
viru
host
interact
eventu
virogenom
research
also
lead
new
treatment
diseas
caus
virus
whole
genom
sequenc
viru
host
repres
complet
collect
possibl
antivir
target
classic
antivir
drug
discoveri
focus
viral
gene
product
howev
limit
number
viral
target
rapid
emerg
drugresist
mutat
mani
viral
system
make
search
host
cell
target
attract
altern
modern
virolog
antivir
drug
discoveri
thu
expect
impact
dramat
function
genom
method
widespread
use
method
reflect
issu
major
virolog
journal
rare
publish
without
articl
includ
reli
function
genom
experi
particular
dna
microarray
howev
publish
studi
limit
show
given
viru
induc
repress
given
set
gene
futur
challeng
howev
determin
myriad
host
cell
gene
product
essenti
viru
surviv
viral
induc
diseas
progress
gene
product
repres
target
inhibit
viru
infect
pathogenesi
virusinduc
tumor
format
recent
breakthrough
gene
knockdown
technolog
expect
acceler
pace
host
cell
pathway
crucial
viru
replic
identifi
furthermor
diagnost
virolog
impact
microarray
technolog
probe
thousand
viral
speci
strain
match
unknown
specimen
highlight
publish
asyet
unpublish
studi
use
dna
microarray
gene
knockdown
method
virolog
thorough
discuss
widespread
use
microarray
technolog
biomedicin
beyond
scope
review
mani
excel
paper
cover
subject
depth
briefli
microarray
glass
silicon
nylon
platform
contain
oligoor
polynucleotid
target
ident
complementari
known
gene
interrog
biolog
sampl
perform
synthesi
sampl
mrna
fluoresc
label
probe
hybrid
target
sequenc
gene
express
quantifi
measur
fluoresc
emiss
confoc
laser
scanner
abil
immobil
differ
gene
singl
array
enabl
examin
transcript
activ
entir
eukaryot
genom
parallel
howev
microarray
adapt
investig
specifi
target
sequenc
examin
viral
gene
host
gene
combin
thu
accomplish
singl
array
technolog
also
use
immobil
specif
probe
mani
differ
viral
speci
differ
viral
strain
complex
dna
virus
mani
common
virus
retrovirus
papillomavirus
parvovirus
small
genom
often
gene
therefor
use
microarray
examin
gene
express
virus
practic
case
techniqu
northern
blot
quantit
rtpcr
qpcr
appropri
howev
microarray
use
genotyp
small
virus
character
strain
variabl
identif
viru
type
present
clinic
sampl
highdens
oligonucleotid
array
use
character
sequenc
variabl
hiv
quasispeci
patient
sampl
oligonucleotid
array
appli
correl
progress
cervic
cancer
presenc
hpv
genotyp
particularli
clever
studi
joe
de
risi
laboratori
construct
microarray
use
polynucleotid
conserv
region
broad
rang
common
virus
use
random
pcr
amplif
infect
sampl
detect
infect
virus
examin
specif
pattern
hybrid
recent
techniqu
confirm
agent
sever
acut
respiratori
syndrom
sar
member
coronaviru
famili
cdc
press
releas
march
sampl
sar
patient
react
probe
avian
bovin
coronavirus
microarray
allow
simultan
diagnosi
multistrain
viral
infect
clinic
specimen
also
identif
new
viru
type
see
furthermor
diagnost
microarray
import
applic
field
biolog
warfar
bioterror
dna
microarray
abl
rapidli
diagnos
individu
exposur
differ
biothreat
poxvirus
plagu
anthrax
tularemia
method
also
use
determin
whether
viral
strain
type
use
attack
genet
alter
viral
genom
microarray
use
determin
complex
transcript
program
larger
virus
especi
member
herpesviru
famili
instanc
transcript
program
kilobas
human
cytomegaloviru
hcmv
genom
map
chamber
colleagu
use
oligonucleotid
array
repres
hcmv
open
read
frame
orf
function
express
pattern
mani
hcmv
gene
still
unknown
classif
might
help
character
unknown
orf
eg
nonstructur
protein
gener
immedi
earli
earli
gene
wherea
structur
protein
often
late
gene
transcript
analysi
tumorigen
herpesviru
kaposi
sarcomaassoci
viru
kshv
human
herpesviru
type
also
examin
microarray
viru
mostli
latent
infect
transform
cell
lytic
replic
induc
either
spontan
small
percentag
cell
artifici
use
phorbol
ester
cultur
correl
viral
gene
express
latent
lytic
phenotyp
investig
use
nylon
membran
glass
slidebas
microarray
jenner
colleagu
measur
kshv
transcript
latent
infect
cell
cultur
lysisinduc
uninduc
time
cours
hr
express
level
gene
group
accord
similar
pattern
express
time
point
treatment
cluster
analysi
interestingli
approach
show
gene
cluster
typic
lytic
gene
previous
misclassifi
latent
use
method
express
level
high
small
percentag
cell
undergo
spontan
lytic
replic
therebi
contamin
strictli
latent
sampl
larg
dna
virus
poxvirus
also
excel
candid
research
emerg
smallpox
potenti
agent
bioterror
recent
monkeypox
outbreak
renew
interest
find
new
therapeut
diagnost
immunolog
target
improv
diagnosi
treatment
vaccin
strategi
poxivirus
viral
genom
array
also
allow
phenotyp
classif
viral
mutant
instanc
gene
express
examin
use
microarray
herp
simplex
viru
type
employ
wild
type
mutant
strain
lack
immediateearli
gene
although
mutant
use
studi
well
character
conceiv
unknown
viral
mutant
classifi
accord
transcriptom
fingerprint
manner
similar
compendium
approach
describ
yeast
particularli
appeal
use
approach
character
classifi
randomli
gener
mutant
target
mutant
much
progress
made
creat
random
transposon
librari
herpesviru
genom
clone
bacteri
artifici
chromosom
bac
transcript
profil
observ
hcmv
experi
agre
strongli
previou
studi
gene
express
use
altern
techniqu
eg
northern
blot
rnase
protect
assay
primer
extens
thu
valid
use
microarray
examin
gene
transcript
complementari
approach
viral
mutant
character
studi
role
manipul
host
cell
transcript
profil
delet
nonessenti
gene
often
result
normal
phenotyp
tissu
culturethat
mutant
viru
behav
similar
wild
type
tradit
assay
singlestep
multistep
growth
curv
howev
microarray
fingerprint
mutant
might
differ
wild
type
delet
gene
might
involv
manipul
host
cell
pathway
essenti
vitro
import
role
vivo
exampl
situat
laboratori
shown
fig
mutant
cmv
lack
nonessenti
gene
grew
much
like
wild
type
fibroblast
howev
microarray
analysi
reveal
dramat
differ
transcript
profil
fibroblast
infect
mutant
versu
wildtyp
viru
addit
regul
similar
set
gene
wild
type
mutant
viru
induc
repress
uniqu
set
gene
regul
cell
infect
wild
type
result
help
elucid
function
nonessenti
viral
gene
also
could
use
classifi
viral
mutant
gener
random
approach
investig
host
cell
transcript
chang
respons
viru
infect
viral
protein
express
vigor
area
microarray
research
past
year
last
count
juli
refer
contain
word
microarray
viru
pubm
literatur
databas
describ
host
cell
respons
viral
infect
given
viru
replic
involv
use
manipul
multipl
host
protein
molecular
process
cellular
pathway
relat
transcript
translat
signal
transduct
metabol
host
defens
cell
cycl
control
review
commonli
alter
respons
result
infect
divers
viru
type
transcript
chang
viral
infect
cell
either
result
antivir
provir
bystand
host
respons
common
antivir
respons
express
interferonstimul
gene
isg
often
observ
infect
divers
unrel
virus
isg
creat
cellular
state
viru
replic
block
thu
natur
select
pressur
circumv
impair
host
respons
recent
review
see
abil
prevent
inhibit
limit
induct
might
therefor
contribut
virul
repres
target
pathway
antivir
treatment
antivir
therapi
conceiv
target
viral
protein
interfer
induct
isg
thu
releas
innat
immun
respons
combat
viral
infect
antihost
strategi
use
virus
complic
transcriptom
analysi
involv
interfer
cellular
rna
metabol
global
inhibit
transcript
rna
degrad
appear
gene
repress
compar
analysi
bia
toward
gene
downregul
inde
observ
influenza
well
hsv
interestingli
case
sever
host
transcript
upregul
despit
massiv
nonspecif
downregul
host
cell
mrna
picornavirus
induc
degrad
mrna
cap
bind
complex
therebi
inhibit
cellular
gene
express
prevent
recruit
ribosom
subunit
cap
follow
translat
gene
occur
contain
intern
ribosom
entri
site
ire
mani
viral
gene
select
isol
mrnapolysom
complex
polioviru
infect
deplet
uninfect
cell
johann
et
al
subsequ
use
microarray
identifi
cellular
gene
translat
polioviru
infect
inde
small
group
cellular
gene
identifi
transcrib
despit
lack
cap
infect
cell
although
gene
divers
function
seem
possibl
intern
ribosom
entri
site
evolv
overcom
block
picornavirus
thu
microarray
analysi
polysomefract
use
screen
host
cell
mrna
surviv
viral
attack
thu
potenti
repres
novel
antivir
host
factor
contrast
host
pathway
repres
antivir
respons
other
might
benefici
even
essenti
viral
replic
inhibit
provir
factor
offer
novel
avenu
antivir
drug
discoveri
sever
exampl
essenti
host
factor
identifi
tradit
hypothesisdriven
method
recent
review
see
addit
nonhypothesisdriven
global
gene
express
profil
reveal
host
cell
gene
promot
viral
growth
howev
challeng
pick
gene
might
import
viral
replic
sever
investig
includ
laboratori
chose
certain
microarrayidentifi
differenti
regul
gene
associ
interest
biolog
characterist
display
unusu
express
pattern
instanc
shenk
group
notic
dna
microarray
experi
sever
gene
regul
prostaglandin
metabol
induc
human
cytomegaloviru
one
induc
gene
lead
synthesi
prostaglandin
e
thu
modul
cellular
gene
express
immun
function
base
initi
observ
zhu
et
al
recent
demonstr
hcmv
replic
requir
function
author
show
specif
inhibitor
lead
decreas
yield
hcmv
titer
furthermor
addit
presenc
inhibitor
restor
normal
hcmv
replic
intriguingli
viru
close
relat
hcmv
infect
rhesu
macaqu
actual
carri
homologu
genom
emphas
import
host
cell
gene
cytomegaloviru
reproduct
recent
exampl
jay
nelson
laboratori
support
notion
transcript
upregul
host
cell
gene
import
viral
replic
hirsch
j
nelson
per
commun
examin
host
gene
express
human
cell
infect
variou
flavivirus
reveal
signific
upregul
host
cell
kinas
cell
treat
correspond
kinas
inhibitor
small
interf
rna
sirna
specif
block
particular
host
cell
protein
result
nearli
tenfold
decreas
product
west
nile
viru
fig
well
flavivirus
special
case
viru
modul
host
cell
gene
express
function
genom
reveal
novel
target
treatment
viral
oncogenesi
oncogen
transform
involv
misregul
gene
express
cancer
research
field
transcriptom
proteom
immedi
direct
benefit
patient
recent
review
see
virusinduc
transform
infect
cell
occur
viral
oncogen
trigger
cellular
pathway
ultim
overcom
growth
restrict
thu
studi
viral
transform
use
function
genom
method
reveal
target
relev
develop
cancer
gener
laboratori
current
studi
kaposi
sarcoma
ks
viral
induc
tumor
frequent
appear
aidspati
characterist
featur
ks
transform
vascular
endotheli
cell
socal
spindl
cell
process
recapitul
vitro
upon
infect
primari
lifeextend
endotheli
cell
kshv
vitro
model
repres
excel
system
studi
cellular
event
transform
oncogenesi
reproduc
trigger
infect
kshv
microarray
analysi
laboratori
other
reveal
substanti
transcript
chang
spindl
cell
format
upon
infect
kshv
studi
identifi
upregul
oncogen
ckit
host
gene
particularli
interest
involv
nonvir
cancer
also
form
spindl
cell
eg
gastrointestin
stromal
tumor
importantli
signal
transduct
ckit
inhibit
receptor
tyrosin
kinas
inhibitor
imatinib
mesyl
gleevec
inde
treatment
prevent
kshvinduc
spindl
cell
format
vitro
observ
suggest
antitumor
drug
gleevec
might
use
treat
ks
patient
predict
born
recent
clinic
trial
http
treatment
gleevec
cutan
ks
aid
patient
result
clinic
histolog
regress
lesion
result
suggest
ckit
plateletderiv
growth
factor
pdgf
receptor
anoth
target
gleevec
also
present
ks
lesion
repres
valid
target
ks
therapi
exampl
list
earlier
demonstr
principl
function
genom
method
identifi
new
antivir
target
target
treatment
diseas
caus
virus
howev
find
needl
haystack
chang
occur
host
cell
viru
infect
daunt
task
avail
specif
inhibitor
one
reason
choos
studi
particular
host
cell
gene
upregul
viral
infect
cell
howev
recent
year
seen
dramat
improv
gene
knockdown
method
use
antisens
rna
rna
interfer
rnai
compar
earlier
gener
phosphorothio
antisens
molecul
display
mani
nonspecif
effect
new
antisens
oligom
highli
specif
longliv
instanc
phosphordiamid
morpholino
oligom
highli
resist
enzymat
degrad
use
block
translat
mrna
recent
method
analyz
gene
inhibit
studi
rnai
sirna
small
nt
rna
duplex
interfer
transcript
program
direct
degrad
homolog
mrna
rna
gene
silenc
mechan
common
plant
fungi
nematod
drosophila
mammalian
cell
mechan
sirna
cleav
target
sequenc
complet
defin
current
model
propos
dsrna
cleav
nt
atpdepend
process
rnase
iii
enzym
dicer
sirna
thought
form
enzym
complex
rna
induc
silenc
complex
risc
unwind
duplex
sirna
target
complex
recognit
site
target
mrna
cleavag
occur
mrna
degrad
mammalian
cell
synthes
sirna
duplex
lead
sequencespecif
mrna
degrad
without
induc
antivir
interferon
respons
activ
longer
dsrna
molecul
newgener
antisens
oligom
sirna
use
knockdown
express
gene
found
dna
microarray
upregul
viral
infect
cell
organ
make
combin
microarray
knockdown
method
particularli
attract
viral
system
instead
de
novo
induct
microarray
usual
indic
severalfold
chang
level
given
transcript
upon
infect
thu
necessari
complet
shutdown
express
target
suffici
reduc
level
induct
back
preinfect
state
use
vitro
ks
model
appli
morpholino
antisens
dna
oligom
ckit
kshvinfect
endotheli
cell
singl
treatment
suffici
inhibit
foci
format
process
take
sever
day
develop
similar
result
obtain
sirna
ckit
fig
establish
antisens
approach
work
system
use
method
evalu
larg
number
host
gene
found
induc
kshv
transform
endotheli
cell
present
examin
differ
host
gene
induc
kshv
sever
instanc
observ
inhibit
transform
phenotyp
compar
ckit
antisens
sirna
mose
k
h
unpublish
observ
correspond
gene
repres
known
novel
oncogen
potenti
new
target
therapi
ks
well
cancer
viral
system
sirna
target
viral
host
cell
gene
success
use
inhibit
viral
replic
p
gene
nonseg
negativestrand
rna
viru
respiratori
synciti
viru
select
silenc
result
decreas
viral
progeni
loss
syncytia
format
polioviru
dsrna
viru
reduc
titer
treat
sirna
capsid
viral
polymeras
gene
confirm
cytoplasm
rna
viru
inhibit
sirna
howev
polioviru
singl
nucleotid
differ
sirna
target
region
lead
escap
mutant
suggest
multipl
target
region
need
gener
therapeut
purpos
similarli
sirna
duplex
target
variou
hiv
gene
inhibit
hiv
replic
addit
decreas
level
sirna
result
decreas
hiv
entri
spread
moreov
target
downstream
nuclear
factor
kb
nfkb
gene
thought
involv
stimul
hiv
gene
express
decreas
replic
similarli
human
papillomaviru
hepat
c
viru
replic
recent
modul
sirna
differ
vectorbas
sirna
approach
also
develop
base
polymeras
iii
promot
express
rnai
molecul
small
hairpin
rna
structur
process
dicer
type
express
cassett
incorpor
retrovir
vector
stabl
deliveri
express
recent
therapeut
potenti
sirna
demonstr
retrovir
deliveri
sirna
could
inhibit
mutant
kra
human
pancreat
carcinoma
lead
loss
tumorigenc
therapeut
potenti
rnai
vivo
also
demonstr
mice
although
result
demonstr
sirna
inhibit
wide
varieti
virus
opinion
real
potenti
techniqu
use
valid
host
cell
product
import
viru
replic
viral
pathogenesi
describ
earlier
prescreen
dna
microarray
identifi
potenti
host
cell
target
howev
even
bolder
approach
bypass
microarray
altogeth
use
wholegenom
knockdown
approach
given
system
examin
subsequ
viru
replic
abil
although
approach
still
difficult
implement
mammalian
system
owe
larg
still
unknown
number
gene
associ
cost
proofofprincipl
studi
success
undertaken
drosophila
cell
take
advantag
complet
drosophila
genom
rnai
extrem
effici
primit
eukaryot
n
perrimon
laboratori
harvard
medic
school
use
highthroughput
rnai
screen
base
dsrna
correspond
everi
known
drosophila
gene
monitor
viral
replic
schneider
cell
approach
reveal
dozen
host
cell
gene
product
essenti
viral
replic
replic
host
cell
cherri
n
perrimon
per
commun
whole
humangenom
sirna
librari
avail
possibl
use
similar
approach
identifi
complet
set
human
gene
requir
virus
complet
replic
although
function
genom
studi
virolog
focu
catalog
global
transcript
translat
event
proofofprincipl
studi
emerg
demonstr
detect
chang
event
requir
desir
viru
replic
pathogenesi
valid
could
achiev
use
smallmolecul
inhibitor
dominantneg
protein
howev
recent
revolut
gene
inhibit
antisens
sirna
significantli
facilit
valid
larg
number
potenti
target
identifi
dna
microarray
method
moreov
wholegenom
screen
sirna
enabl
complet
evalu
valid
role
host
cell
gene
product
viral
replic
approach
thu
repres
unpreced
opportun
character
function
host
gene
product
essenti
viru
replic
diseas
